upgraded: BTIG Research Recommends TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock to “a Buy”
BTIG Research raised the price target for the TRACON Pharmaceuticals Inc (NASDAQ:TCON) stock from “a Neutral” to “a Buy”. The rating was released on April 16, 2021, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $18. The stock was reiterated by Needham, […]